Arthritis Research & Therapy

official impact factor 4.36

Open Access

Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease

Dirk M Wuttge*, Marie Wildt, Pierre Geborek, Frank A Wollheim, Agneta Scheja and Anita Åkesson

Arthritis Research & Therapy 2007, 9:R85 doi:10.1186/ar2284

Accesses  

  • Last 30 days: 30 accesses
  • Last 365 days: 422 accesses
  • All time: 2718 accesses